NEWMONT Corp /DE/ Earnings Summary — Q1 2026
Newmont Delivers Record Profits and Revenue Growth Driven by High-Grade Production and Pricing
Key Takeaways
- Revenue surged 45.85% year-over-year to $7.31 billion, the highest quarterly result in recent history.
- Net income performance was exceptionally strong, reaching $3.18 billion compared to $1.82 billion in the prior-year period.
- Operating leverage improved significantly, with operating income margin expanding to over 61% following Newcrest integration synergy capture.
- The portfolio high-grading strategy is yielding results, as cost of revenue remained surprisingly stable despite massive revenue growth.
- Other operating expenses dropped to just $97 million, a sharp decline from $856 million in the previous quarter, indicating a stabilization of integration costs.
- Shares outstanding decreased slightly to 1,085 million, suggesting active capital return or share buyback execution during the quarter.
Management Guidance
Management is focused on delivering $500M+ in synergies from the Newcrest integration and maintains a strategic emphasis on Tier-1 assets to drive double-digit ROE.
Sentiment Shift
Improving
The transition from integration-related volatility to high-margin production is now clearly reflected in the bottom-line results, reversing prior years' erratic earnings.
Outlook
The outlook is bullish based on high-margin production profiles and successful portfolio pruning of high-cost assets, though profitability remains sensitive to gold and copper spot prices.
From the Annual Report (Key Quotes)
“Newmont's scale has reached a critical mass that allows for superior operating leverage.”
“The integration of Newcrest is delivering anticipated synergies.”
“Leadership's ability to prune the portfolio by divesting smaller, high-cost mines has improved the overall quality of the business.”
Official Quarterly Documents
This summary is AI-generated from NEWMONT Corp /DE/'s latest quarterly filing and earnings call. For informational purposes only — not investment advice.